B. 1. Les, . Entreprises, and . Medicament, Marché mondial, L'économie du médicament. 05.09

I. Institute, . Healthcare, and . Informatics, The global use of medicines outlook through 2017 Disponible sur: http://www.quotidianosanita.it/allegati/allegato1501906.pdf 3. Fédération Nationale de l'Information Médicale. Le marché mondial de l'industrie pharmaceutique : analyse et perspectives, Internet]. [cité 26 oct 2017], 2013.

A. Disponible-sur and A. , Pays du monde. 03 Disponible sur: https What's next for pharma in emerging markets? McKinsey & Company Disponible sur: http://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our- insights/whats-next-for-pharma-in-emerging-markets 7. Nations Unies. Situation et perspectives de l'économie mondiale. 2017. [Internet]. [cité 17 sept 2017] Disponible sur: https://www.un.org/development/desa/dpad/wp- content/uploads/sites Disponible sur: http://trade.gov/topmarkets/pdf/Pharmaceuticals_Executive_Summary.pdf 9. European Federation of Pharmaceutical Industries and Associations. The Pharmaceutical Industry in Figures Disponible sur: https://www.insee.fr/fr/metadonnees/definition/c1248 13. Institut National de la Statistique et des Etudes Economiques, IMS HEALTH. Pharmerging markets, Picking a pathway to success. 2013. [Internet]. [cité 26 févr 2017 Disponible sur Organisation Mondiale de la Santé. Stratégie pharmaceutique de l'OMS : cadre d'action pour les médicaments essentiels et politiques pharmaceutiques Disponible surCL-15-Final.for.Printing.pdf 17. Journal officiel des Communautés européennes, p.341, 2000.

C. De-commerce-et-d-'industrie-de-région-paris-ile-de-france, Certificats d'exportation de médicaments à usage humain et dispositifs médicaux Disponible sur: https://www.entreprises.cci-parisidf.fr/documentsTarifs-prestations.pdf/c20a4a02-eca9-416c-abfb- 34b6a2a7e63f 26, 14.02.2017. [Internet]. [cité 9 oct 2017, 20152.

C. Thomson and R. , Regulatory summary continuously monitored and updated based on regulatory changes Disponible sur: https://cortellis.thomsonreuterslifesciences.com/ngg, Internet]. [cité 9 avr 2017] Journal officiel des Communautés européennes. L18/1. RÈGLEMENT (CE) N° 141, 1999.

P. Bridge, M. Orphan, . A. In, A. Sharma, R. J. Arnold et al., Guidelines and regulatory requirements to help orphan drug products enter the Asian market Disponible surOrphan-Drugs-in-Asia-2014 Orphan drug: Development trends and strategies 28.10.2010 The role of globalization in drug development and access to orphan drugs: orphan drug legislation in the US/EU and in Latin America ICH. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Achieving Simultaneous Submission in an Electronic Regulatory Market International council for harmonisation of technical requirements for pharmaceuticals for human use. Organisation of the Common Technical Document for the registration of pharmaceuticals for human use M4, current step 4 version, Disponible sur290?9. 32. ALMALKI Ziyad S. and al. Access to orphan drugs in the Middle East: Challenge and perspective. Intractable & Rare Diseases Research Patent term extensions and regulatory exclusivities for pharmaceuticals in Asia and South America. MORRISON & FOERSTER LLP. 27, pp.5-290, 1000.

C. De-commerce, Industrie de Région Paris Ile-de-France. Certificats d'exportation de médicaments à usage humain et dispositifs médicaux

C. De-commerce-et-d-'industrie-de-région-paris-ile-de-france, . Avis, . Demandeurs, . Aux-certificats-d-'exportation, . De-medicaments-a et al., Disponible sur: http://www.entreprises.cci-parisidf.fr/c/document_library/get_file?uuid=b5b86967-f88b-4e38-bcc4- a43428adce41&groupId=10139 41. SAHL, Anna. Relevance of a Certificate of Pharmaceutical Product for Registration and Life Cycle Management of Imported Drugs. How is the WHO Certification Scheme implemented by National Health Authorities outside of the ICH? Disponible sur: http://dgra.de/media/pdf/studium/masterthesis/master_sahl_a.pdf 42. World Health Organization. Good Manufacturing Practices World Health Organization. WHO good manufacturing practices for pharmaceutical products: main principles, 2014.

C. Kothari, P. R. Kothari, and C. , Regulatory Need: Harmonized PIC/S GMP, Its Overview and Comparison with WHO GMP. 28.08 Pharm Regul Aff Open Access [Internet]. 28 août 2015 [cité 19 juin 2017]; Disponible sur: https://www.omicsgroup.org/journals/regulatory-need-harmonized-pics-gmp-its-overview- and-comparison-with-who-gmp-2167-7689-1000150.php?aid=60823 46. The Pharmaceutical Inspection Co-operation Scheme, 2015.

C. On, . Of, . Technical, . For, . Of et al., Disponible sur: http://www.ich.org/fileadmin/Public_Web_Site, R2). 6.02.2003. [Internet]. [cité 2 juill 2017]. Disponible sur, 2009.

G. Prat and A. , Disponible sur: http://ec.europa.eu A practical overview of requirements for drug registration in Latin America, de la Commission du 24 novembre 2008 concernant l'examen des modifications des termes, p.25, 2003.